Evidence map›Paper›PMID 29276652›Full record

ArticleCurrent obstetrics and gynecology reports2017

Endometriosis: Epidemiology, Diagnosis and Clinical Management.

Parveen Parasar, Pinar Ozcan, Kathryn L Terry

2 registry-linked trialsOpen access · greenAbstract read
In one paragraph

Article in Current obstetrics and gynecology reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 390 papers, 10 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
390citing papers in PubMed, 10 pooled it
37.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06577233 phase4recruitingnot on this mapstarted 2024, after this paper: background citation

Superior Hypogastric Nerve Plexus Block With Bupivacaine for Postoperative Pain Reduction Following Robotic Assisted Resection of Endometriosis: A Randomized Control Trial

TypeinterventionalSponsorBaylor College of MedicineRan2024 to 2025Enrolled60ConditionsEndometriosisArmsBupivacaine Hydrochloride, Normal saline
NCT06792318 narecruitingnot on this mapstarted 2025, after this paper: background citation

Use of Fibroblast Activation Protein Inhibitor (FAPI) PET-CT Before Surgery in Patient with Endometriosis

TypeinterventionalSponsorZiv HospitalRan2025 to 2027Enrolled30ConditionsEndometriosisArmsFAPI PET-CT
3 · Its place in the literature

Who cites it

390 citing papers in PubMed, 10 syntheses or guidelines pooled it, 737 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Pooled it
  10. Pooled it
  11. Trial
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Review
  20. Article

330 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 2 countries.

Parveen ParasarBoston Center for Endometriosis, Boston Children's and Brigham and Women's Hospitals, 333 and 221 Longwood Avenue, Boston, MA 02115, USA.
Pinar OzcanCenter for Infertility and Reproductive Surgery, Department of Obstetrics, Gynecology, and Reproductive Biology, Brigham and Women's Hospital and Harvard Medical School, 75 Francis Street, Boston, MA 02115, USA.
Kathryn L TerryObstetrics and Gynecology Epidemiology Center, Brigham and Women's Hospital and Harvard Medical School, 221 Longwood Avenue, Boston, MA 02115, USA.
Brigham and Women's Hospital · USDana-Farber/Boston Children's Cancer and Blood Disorders Center · USHarvard University · US

Funding

Redefining Normal: personalized CA125 cutpoints for ovarian cancer screeningR01CA193965 · NCI · BRIGHAM AND WOMEN'S HOSPITAL · PI TERRY, KATHRYN L. · 2016 to 2019
$1.6M
NCI NIH HHS R01 CA193965
6 · The paper itself

Abstract

purpose of reviewEndometriosis is a disease of adolescents and reproductive-aged women characterized by the presence of endometrial tissue outside the uterine cavity and commonly associated with chronic pelvic pain and infertility. Here we review the epidemiology of endometriosis as well as potential biomarkers for detection and with the goal of highlighting risk factors that could be used in combination with biomarkers to identify and treat women with endometriosis earlier.. RECENT

findingsEarly age at menarche, shorter menstrual length, and taller height are associated with a higher risk of endometriosis while parity, higher body mass index (BMI) and smoking are associated with decreased risk. Endometriosis often presents as infertility or continued pelvic pain despite treatment with analgesics and cyclic oral contraceptive pills. SUMMARY: Despite a range of symptoms, diagnosis of endometriosis is often delayed due to lack of non-invasive, definitive and consistent biomarkers for diagnosis of endometriosis. Hormone therapy and analgesics are used for treatment of symptomatic endometriosis. However, the efficacy of these treatments are limited as endometriosis often recurs. In this review, we describe potential diagnostic biomarkers and risk factors that may be used as early non-invasive

Indexed as

BiomarkersEndometriosisInfertilityManagementPain

Identifiers

PMID29276652
PMCPMC5737931
OpenAlexW2581986521

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.